Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence

Post time 5 day(s) ago

journal：Cardiovascular & Hematological Disorders-Drug Targets

Authors：Konstantinos N. Tentolouris; Ioanna A. Anastasiou; Iordanis Mourouzis; Costantinos Pantos; Nikolaos Tentolouris

Published date：2025-7-

DOI：10.2174/011871529x356362250324080014

PDF link：https://www.eurekaselect.com/art ... X356362250324080014

Article link：https://doi.org/10.2174/011871529x356362250324080014

Article Source：Bentham Science Publishers Ltd.。

Remark：

Post time 5 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Bentham] Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Bentham] Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Bentham] Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence